Mackaness James H's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Jan 6, 2025
- Accession no.
- 0001415889-25-000955
- Filed
- Jan 6, 2025
- Trade date
- Jan 2-3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $360.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mackaness James HCIK 0001422484 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Common Stock | SSaleDisposed | −3,762 | $45.37 | −$170,681.94 | 115,410 | Direct | |
| Jan 2, 2025 | Common Stock | SSaleDisposed | −321 | $45.92 | −$14,740.32 | 115,089 | Direct | |
| Jan 3, 2025 | Common Stock | SSaleDisposed | −3,791 | $46.18 | −$175,068.38 | 111,298 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.